Identity
- Trade Name
- ARCHITECT FDA UDI
- Generic Name
- Gentamicin therapeutic drug monitoring IVD, calibrator FDA UDI
- Device Name
- ARCHITECT iGentamicin Calibrators FDA UDI
- Model / Reference
- 1P31-01 FDA UDI
- Description
- ARCHITECT iGentamicin Calibrators FDA UDI
Identifiers
- Catalog Number
- 01P3101 FDA UDI
- Primary DI / UDI-DI
- 00380740001735 FDA UDI
- 510(k) Number
- K102699 FDA UDI
- FDA Product Code
- LCD FDA UDIDLJ FDA UDI
- GMDN Term
- Gentamicin therapeutic drug monitoring IVD, calibrator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.3450 FDA UDI862.3200 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Gentamicin therapeutic drug monitoring IVD, calibrator
Architect by Abbott — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Gentamicin therapeutic drug monitoring IVD, calibrator.
- Emit® 2000 Gentamicin Plus Assay — Siemens Healthcare Diagnostics · Class II
- VITROS — Ortho-Clinical Diagnostics · Class II
- Syva® Emit® 2000 Gentamicin Plus Calibrators — Siemens Healthcare Diagnostics · Class II
Cleared under the same submission
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Abbott
Sources (1)
- FDA UDI f3ab15bd-b436-45c0-999e-53451589c172 37 fields · synced Jun 1, 2026